Lakefront Biotherapeutics | GLPG - Ebitda





Ebitda Cambiamento Data
argenx SE USD 539M 6M 2026-09
AstraZeneca USD 7.46B 2.3B 2026-09
Biogen USD 450.8M 198.9M 2026-06
Genmab DKK 401M 186M 2026-06
Gilead Sciences USD -9.31B 12.82B 2026-06
GlaxoSmithKline GBP 3.51B 734M 2026-06
GRIFOLS EUR 473M 120M 2026-06
Hikma Pharmaceutical USD 369M 84M 2024-12
Incyte USD 778.57M 410.6M 2026-06
Merck EUR 1.6B 69M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 8.62B 2.14B 2026-09
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 5.79B 2.1B 2026-09
UCB EUR 1.6B 570M 2025-12
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06